Phase Holographic Imaging (PHI) is taking back control of its distribution and introducing a new sales structure. In an interview with BioStock, Håkan Rosvall, Chief Commercial Officer, talks about the goals behind the change, the expected benefits and the challenges the company sees ahead.
Watch the interview with the CCO Håkan Rosvall, in English, below.
The content of BioStock's news and analysis is independent, but BioStock's operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.